pirfenidone has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armendáriz-Borunda, J; Castrejón-Gómez, E; López-Reyes, A; Ruiz-Corro, L; Salazar-Montes, A | 1 |
| Armendariz-Borunda, J; Arrevillaga-Boni, G; Gonzalez-Cuevas, J; Martinez-Rizo, AB; Navarro-Partida, J; Ortiz-Navarrete, V | 1 |
2 other study(ies) available for pirfenidone and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Potent antioxidant role of pirfenidone in experimental cirrhosis.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Bilirubin; Carbon Tetrachloride; Catalase; Collagen Type I; Common Bile Duct; Hepatocyte Growth Factor; Ligation; Liver; Liver Cirrhosis, Experimental; Malondialdehyde; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Onium Compounds; Oxidative Stress; Proto-Oncogene Proteins c-met; Pyridones; Rats; Rats, Wistar; Superoxide Dismutase; Transforming Growth Factor beta | 2008 |
Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cells, Cultured; Collagen Type I; DNA; Down-Regulation; Drug Evaluation, Preclinical; GATA3 Transcription Factor; Gene Expression; Interferon-gamma; Interleukin-4; Liver; Liver Cirrhosis, Experimental; Male; p38 Mitogen-Activated Protein Kinases; Pyridones; Rats; Rats, Wistar; T-Box Domain Proteins; Th1 Cells; Th2 Cells | 2012 |